Does Human Botulinum Neurotoxin Ab Immune Globulin Interact with Measles Vaccine?
CDI records a moderate classification for Human Botulinum Neurotoxin Ab Immune Globulin and Measles Vaccine. The stored summary is: Antibodies in BabyBIG may interfere with immune response to measles vaccine; vaccination should be deferred until 6 months after BabyBIG administration. The mechanism involves passive antibody transfer interferes with live virus vaccine response. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
Evidence status
A current label comparison is not yet available for this record. The summary and severity are stored CDI information; they have not been independently validated on this page against the exact product label.
Confirm the medicine, formulation, route, and applicable warning with your pharmacist or prescriber. Independent clinical review has not been recorded.
Saved label reference on DailyMed. This identifier has not been checked here as support for the current claim.
- Stored CDI classification
- Moderate
- Human Botulinum Neurotoxin Ab Immune Globulin Class
- Human Immunoglobulin G
- Management
- Confirm exact products with your pharmacist
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Passive antibody transfer interferes with live virus vaccine response
What To Tell Your Doctor or Pharmacist
If you are taking Human Botulinum Neurotoxin Ab Immune Globulin and your doctor is considering prescribing Measles Vaccine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider